Insider · CIK 0001282829

LANGECKER PETER

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001282829

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-08-08	OTLCOncotelic Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+73K sh	—	—	77,993
2013-06-28	OTLCOncotelic Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,000 sh	$2.75	+$8,250	5,000
2013-06-25	OTLCOncotelic Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,000 sh	$2.79	+$5,572	2,000
2013-02-27	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+8,333 sh	—	—	8,333
2012-07-30	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2011-12-08	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2010-09-15	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2010-04-27	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2009-06-29	OTLCOncotelic Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2009-05-21	DURECT CORPIncentive Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+8,251 sh	—	—	8,251
2009-05-21	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+57.7K sh	—	—	57,749
2009-01-27	DURECT CORPIncentive Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+7,815 sh	—	—	7,815
2009-01-27	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+117K sh	—	—	117,185
2008-01-18	DURECT CORPIncentive Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+19.2K sh	—	—	19,230
2008-01-18	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+90.8K sh	—	—	90,770
2006-05-01	DURECT CORPIncentive Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+85.7K sh	—	—	85,652
2006-05-01	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+114K sh	—	—	114,348
2005-06-17	BGMSBio Green Med Solution, Inc. · Director (Stock Option Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2005-06-17	BGMSBio Green Med Solution, Inc. · Director (Stock Option Right to Buy)A Award	Director	AAward	+2,500 sh	—	—	12,500
2005-06-17	BGMSBio Green Med Solution, Inc. · Director (Stock Option Right to Buy)A Award	Director	AAward	+2,500 sh	—	—	15,000
2005-02-04	BGMSBio Green Med Solution, Inc.P Purchase	Director	PPurchase	+3,000 sh	$1.88	+$5,627.7	5,000

Recent filings

Accepted (ET)
Aug 94
OXIGENE INC0001181431-13-044022
SEC(opens sec.gov)
Jul 14
OXIGENE INC0001181431-13-037361
SEC(opens sec.gov)
Jun 264
OXIGENE INC0001181431-13-036819
SEC(opens sec.gov)
Feb 284
LANGECKER PETER0001181431-13-013362
SEC(opens sec.gov)
Aug 14
LANGECKER PETER0001181431-12-043070
SEC(opens sec.gov)
Dec 124
LANGECKER PETER0001181431-11-059791
SEC(opens sec.gov)
Sep 174
LANGECKER PETER0001181431-10-047127
SEC(opens sec.gov)
Apr 294
LANGECKER PETER0001181431-10-023500
SEC(opens sec.gov)
Jun 304
LANGECKER PETER0001181431-09-032812
SEC(opens sec.gov)
May 264
LANGECKER PETER0001082038-09-000014
SEC(opens sec.gov)
Jan 284
LANGECKER PETER0001082038-09-000007
SEC(opens sec.gov)
Jan 224
DURECT CORP0001082038-08-000004
SEC(opens sec.gov)
May 34
DURECT CORP0001082038-06-000012
SEC(opens sec.gov)
Jun 174
XCYTE THERAPIES INC0001130166-05-000041
SEC(opens sec.gov)

Companies

Address

C/O OXIGENE, INC. 701 GATEWAY BLVD.

SOUTH SAN FRANCISCO, CA, 94080